Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-14 09:40 am Purchase | 2022-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | AVORO CAPITAL ADVISORS LLC | 4,325,000 8.900% | 1,013,566![]() (+30.61%) | Filing History |
2023-02-14 09:38 am Purchase | 2022-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | AVORO CAPITAL ADVISORS LLC | 7,550,000 7.600% | 750,000![]() (+11.03%) | Filing History |
2023-02-14 09:37 am Sale | 2022-12-31 | 13G | IVERIC bio, Inc. ISEE | AVORO CAPITAL ADVISORS LLC | 6,750,000 4.960% | -500,000![]() (-6.90%) | Filing History |
2023-02-14 09:37 am Purchase | 2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | AVORO CAPITAL ADVISORS LLC | 1,660,000 9.700% | 235,000![]() (+16.49%) | Filing History |
2023-02-14 09:37 am Purchase | 2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | AVORO CAPITAL ADVISORS LLC | 3,850,000 7.000% | 3,850,000![]() (New Position) | Filing History |
2023-02-14 09:36 am Purchase | 2022-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | AVORO CAPITAL ADVISORS LLC | 10,625,000 9.600% | 2,069,445![]() (+24.19%) | Filing History |
2023-02-14 09:36 am Sale | 2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | AVORO CAPITAL ADVISORS LLC | 3,150,000 6.300% | -85,000![]() (-2.63%) | Filing History |
2023-02-14 09:35 am Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | AVORO CAPITAL ADVISORS LLC | 26,800,000 9.500% | 8,300,000![]() (+44.86%) | Filing History |
2023-02-14 09:35 am Purchase | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | AVORO CAPITAL ADVISORS LLC | 3,060,000 6.700% | 1,595,000![]() (+108.87%) | Filing History |
2023-02-14 09:34 am Sale | 2022-12-31 | 13G | United Therapeutics Corporation UTHR | AVORO CAPITAL ADVISORS LLC | 2,865,000 6.300% | -170,000![]() (-5.60%) | Filing History |
2023-02-14 09:34 am Purchase | 2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | AVORO CAPITAL ADVISORS LLC | 5,555,555 9.600% | 480,555![]() (+9.47%) | Filing History |
2023-02-14 09:33 am Purchase | 2022-12-31 | 13G | Krystal Biotech, Inc. KRYS | AVORO CAPITAL ADVISORS LLC | 1,410,000 5.500% | 1,410,000![]() (New Position) | Filing History |
2023-02-14 09:33 am Purchase | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | AVORO CAPITAL ADVISORS LLC | 3,100,000 5.400% | 3,100,000![]() (New Position) | Filing History |
2023-02-14 09:32 am Sale | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | AVORO CAPITAL ADVISORS LLC | 3,105,000 4.500% | -895,000![]() (-22.38%) | Filing History |
2023-02-14 09:32 am Purchase | 2022-12-31 | 13G | DICE Therapeutics, Inc. DICE | AVORO CAPITAL ADVISORS LLC | 2,525,555 5.300% | 2,525,555![]() (New Position) | Filing History |
2023-02-14 09:31 am Sale | 2022-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | AVORO CAPITAL ADVISORS LLC | 7,020,000 4.400% | -1,655,000![]() (-19.08%) | Filing History |
2023-02-14 09:30 am Sale | 2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -695,000![]() (Position Closed) | Filing History |
2022-09-26 5:27 pm Purchase | 2022-09-22 | 13D | Aadi Bioscience, Inc. AADI | AVORO CAPITAL ADVISORS LLC | 3,471,752 14.400% | 1,260,000![]() (+56.97%) | Filing History |
2022-02-11 10:09 am Unchanged | 2021-12-31 | 13G | POINT Biopharma Global Inc. PNT | AVORO CAPITAL ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing History |
2022-02-11 10:08 am Sale | 2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -1,525,000![]() (Position Closed) | Filing History |